These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24447758)

  • 1. Absorb bioresorbable scaffold implantation for the treatment of an ostial chronic total occlusion.
    Gori T; Guagliumi G; Münzel T
    Int J Cardiol; 2014 Mar; 172(2):e377-8. PubMed ID: 24447758
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive Vessel Remodeling and Appearance of Pulsatile Wall Motion at Long-Term Follow-Up After Bioresorbable Scaffold Implantation in a Chronic Total Occlusion.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1635-7. PubMed ID: 26386767
    [No Abstract]   [Full Text] [Related]  

  • 3. Bailout left main bioresorbable vascular scaffolding for the treatment of iatrogenic coronary dissection induced by guiding catheter and sticky ABSORB bioresorbable vascular scaffold balloon.
    Yew KL
    Int J Cardiol; 2015; 187():527-9. PubMed ID: 25846666
    [No Abstract]   [Full Text] [Related]  

  • 4. One-year follow-up optical coherence tomography after implantation of bioresorbable vascular scaffolds for a chronic coronary total occlusion.
    Naganuma T; Latib A; Panoulas VF; Sato K; Miyazaki T; Nakamura S; Colombo A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e157-9. PubMed ID: 25240539
    [No Abstract]   [Full Text] [Related]  

  • 5. New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds.
    Gargiulo G; Mangiameli A; Granata F; Ohno Y; Chisari A; Capodanno D; Tamburino C; La Manna A
    JACC Cardiovasc Interv; 2015 Mar; 8(3):e41-e43. PubMed ID: 25703870
    [No Abstract]   [Full Text] [Related]  

  • 6. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
    Diletti R; Serruys PW; Farooq V; Sudhir K; Dorange C; Miquel-Hebert K; Veldhof S; Rapoza R; Onuma Y; Garcia-Garcia HM; Chevalier B
    Am Heart J; 2012 Nov; 164(5):654-63. PubMed ID: 23137495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifurcation lesions: Bioresorbable vascular scaffold and drug coated balloon, an efficacy association. Lessons from optimal coherence tomography.
    Piraino D; Carella M; Buccheri D; Andolina G
    Int J Cardiol; 2016 Jun; 212():92-3. PubMed ID: 27038711
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioresorbable scaffolds: the fee comes now and the reward comes later.
    Jabbour RJ; Colombo A
    Future Cardiol; 2016 Jul; 12(4):397-400. PubMed ID: 27291396
    [No Abstract]   [Full Text] [Related]  

  • 9. First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.
    Grasso C; Attizzani GF; Patané M; Ohno Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Oct; 168(4):4490-1. PubMed ID: 23890924
    [No Abstract]   [Full Text] [Related]  

  • 10. One-year imaging follow-up of a self-expanding bifurcation drug-eluting stent and bioresorbable scaffold for a complex bifurcation lesion.
    Nakajima A; Kawamoto H; Nakamura S; Tresukosol D
    Coron Artery Dis; 2018 Jun; 29(4):354-356. PubMed ID: 29076827
    [No Abstract]   [Full Text] [Related]  

  • 11. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.
    García-García HM; Schultz C; Duckers E; Regar E; Ligthart J; Serruys PW; van Geuns RJ
    EuroIntervention; 2013 Feb; 8(10):1126-7. PubMed ID: 23014900
    [No Abstract]   [Full Text] [Related]  

  • 13. Fate of Coronary Chronic Total Occlusion Recanalization via Subintimal Tracking With Bioresorbable Vascular Scaffolds: A Temporary Cage for a Permanent New Lumen?
    La Manna A; Ohno Y; Attizzani GF; Chisari A; Giacchi G; Capodanno D; Tamburino C
    JACC Cardiovasc Imaging; 2015 Sep; 8(9):1114-1115. PubMed ID: 25577443
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on interventional cardiology: management of CTO, performance of absorbable scaffolds, coronary vasomotion after DES, and antithrombotics.
    Lüscher TF
    Eur Heart J; 2016 Sep; 37(35):2681-3. PubMed ID: 27678182
    [No Abstract]   [Full Text] [Related]  

  • 15. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute stent thrombosis of a bioresorbable vascular scaffold implanted for ST-segment elevation myocardial infarction.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jun; 174(2):e72-4. PubMed ID: 24784914
    [No Abstract]   [Full Text] [Related]  

  • 17. Culotte Technique With a Bioresorbable Vascular Scaffold: 12 Months' Follow-up.
    Vera Pernasetti L; Gutiérrez H; Ramos B
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):973-974. PubMed ID: 27085839
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary aneurysm without malapposition after bioresorbable vascular scaffold implantation.
    Timmers L; Lim YC; Tan HC; Low AF
    EuroIntervention; 2016 May; 12(1):60. PubMed ID: 27173862
    [No Abstract]   [Full Text] [Related]  

  • 19. Pitfalls of bioresorbable vascular scaffold thrombosis--be sure to cover it all.
    Abu Sharar H; Katus HA; Bekeredjian R
    Int J Cardiol; 2014 Dec; 177(3):1067-8. PubMed ID: 25465842
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds: lessons from optical coherence tomography.
    Sato K; Panoulas VF; Naganuma T; Miyazaki T; Latib A; Colombo A
    Can J Cardiol; 2014 Nov; 30(11):1460.e15-7. PubMed ID: 25442445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.